Foreword

As we look ahead to 2025, the pharmaceutical industry is poised for transformation once again. The increasing integration of AI across all facets of the industry is set to revolutionize drug discovery, development, and commercialization, and the pharma industry must be ready to maximize the opportunities it can bring. The industry must also navigate the very tangible landscape of geopolitical risk. Regional instability along with new regulation could disrupt supply chains and impact global operations, necessitating robust risk management strategies.

With global elections now in the 2024 rearview mirror, can the pharma and medtech markets turn toward stable growth that has stagnated marquee M&A in 2024? Therapy areas such as cancer and obesity are driving this growth. Advances in oncology are particularly noteworthy, with innovative treatments offering new hope for patients through radiopharmaceuticals, combinations, and neoadjuvant therapies. The focus on obesity is intensifying, and pharma is investing in the clinic to find new ways of tackling this age-old problem. Expect to see more study results and patient options launched in 2025.

This eBook dives into the key trends and challenges shaping the year ahead, from geopolitical uncertainties to cutting-edge innovation in AI, oncology, and weight-loss therapies. It is part of In Vivo’s comprehensive Outlook 2025 report, offering critical insights into the forces that will define pharma and medtech’s road ahead.

Access the full eBook today!
''
Citeline may contact you about relevant products, services and content. To opt-out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.

Thank you.




Your download should open in a new window. You can also manually download by clicking the button below.



Related resources

Pink Sheet Podcast Logo
OCT 30, 2024
Podcast
商業化支援サービス

Pink Sheet Podcast: BIOSECURE Act Advances, Trial Diversity Sticks & More

Pink Sheet editors and a reporter discuss implications of the BIOSECURE Act, clinical trial diversity, and more.

Cover for Scrip Asia 100: Innovating For A Global Future report
OCT 29, 2024
Report
商業化支援サービス

Scrip Asia 100: Innovating for a Global Future

Each year we analyze the top 100 companies and the key trends shaping the APAC’s future. This is your go-to resource for navigating the complexities of this crucial market.

Report cover for TechBio
OCT 17, 2024
Report
商業化支援サービス

TechBio: UK Leads Innovation Frontier

TechBio sits at the intersection of data, AI, life science and innovation. This report highlights key companies, deals, and approaches across TechBio.